In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 260 for your search:
Drug:  cyclosporine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: SMD/ATG-CSA/2002, NCT00488436

2.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Under 46
Sponsor: Other
Protocol IDs: UMN-MT-1995-06, UMN-9224, UMN-MT-9506, NCI-V00-1605, NCT00006451

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187

8.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor:
Protocol IDs: WSU-Z-1093-93, NCI-V94-0363

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9421

11.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 12 and over
Sponsor: Other
Protocol IDs: FHCRC-949.00, NCI-V95-0776

12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LEUK-AML-R, EU-95037

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 65
Sponsor: Other
Protocol IDs: JHOC-9333, NCI-V96-0897

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: UNMC-35195, NCI-V96-0918

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 12 to 55
Sponsor: NCI
Protocol IDs: FHCRC-1106.00, NCI-H97-1231

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: J9726 CDR0000066427, P30CA006973, P01CA015396, JHOC-97080106, JHOC-9726, NCI-V98-1453, NCT00003414

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SAKK 33/99, SWS-SAKK-33/99, NCT00004208

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: CPMC-IRB-7608, CPMC-CAMP-014, NCI-G00-1890, NCT00008203

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000068529, ICU-INTERFANT99, UKCCSG-LK-1999-05, EU-20063, EU-20588, NCT00015873

20.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 1 to 29
Sponsor: NCI, Other
Protocol IDs: ASCT0031, COG-ASCT0031, CCG-S9701, NCI-P02-0213, NCT00031824

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 50
Sponsor:
Protocol IDs: FHCRC-122, NCI-V83-0098

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 to 50
Sponsor:
Protocol IDs: FHCRC-127, NCI-V83-0362

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO268, NCI-V84-0067

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 to 60
Sponsor: Other
Protocol IDs: OSU-84HO140, NCI-V84-0071

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 2 to 55
Sponsor:
Protocol IDs: OSU-83HO270, NCI-V84-0070
1     
New Search